Wednesday, February 27th
5 p.m., EM029, Center for Molecular Oncology Conference Room
Brandon Albright, Ph.D.
Going viral: Exploring the dark matter of the microbiome
Wednesday, February 27th
5 p.m., EM029, Center for Molecular Oncology Conference Room
Brandon Albright, Ph.D.
Going viral: Exploring the dark matter of the microbiome
Wednesday, November 28th
5 p.m., EM029, Center for Molecular Oncology Conference Room
Sharoar Golam, Ph.D.
Dr. Jekyll and Mr. Hyde roles of Reticulon 3 in Alzheimer’s Disease
Wednesday, March 28th
5 p.m., EM029, Center for Molecular Medicine Conference Room
Nelson Monteiro, Ph.D.
Dental tissue engineering and dental pain
Wednesday, February 28th
5 p.m., EM029, Center for Molecular Medicine Conference Room
Meagan Cauble, Ph.D.
Nano- and Microstructural Changes in Intervertebral Disc Extracellular Matrix in Health and Degeneration
Wednesday, January 31st
5 p.m., EM029, Center for Molecular Medicine Conference Room
Charan Devarkonda, Ph.D.
CD13 deficiency leads to reduced autophagy, increased oxidative stress and larger atherosclerotic lesions
Wednesday, September 28th
5 p.m., EM029, Center for Molecular Medicine Conference Room
Charles Drinnan, Ph.D.
Treatment and Modelling of Neonatal Lung Diseases Using Patient-Specific Stem Cells
Wednesday, June 29
5 p.m., EM029, Center for Molecular Medicine Conference Room
Erxia Du, Ph.D.
FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice
Wednesday, March 30
5 p.m., EM029, Center for Molecular Medicine Conference Room
Abhijit Rath, Ph.D.
Modeling Lynch Syndrome Associated MSH2 Variants Using CRISPR-Cas9 Engineering in Human Stem Cells
Wednesday, February 24
5 p.m., EM029, Center for Molecular Medicine Conference Room
Tasleem Samji, Ph.D.
TBA
Wednesday, January 27
5 p.m., EM029, Center for Molecular Medicine Conference Room
Lorry Grady, Ph.D.
Investigating the HSV-1 Viral Recombinase Complex: One Sub-unit at a Time